Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
Clinical trial NCT00752141 · COMPLETED
Trial details
- NCT number
- NCT00752141
- Sponsor
- Watson Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.